Ultimo aggiornamento :
19/11/2024
Antimicotico   Amphotericin B cholesteryl sulfate complex  
Iniezione
Stabilità in soluzione Stabilità in miscela Fattori che influenzano la stabilità Compatibilità metodo di iniezione Bibliografia pdf
   Struttura chimica  

Nome commerciale   Nome commerciale     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Amphotec Austria, Gran Bretagna, Grecia, Polonia, Slovenia, Stati Uniti d’America, Turchia
Bibliografia   Iniezione   Bibliografia : Amphotericin B cholesteryl sulfate complex  
tipo pubblicazione
921 Rivista Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1407 Rivista Xu QA, Trissel LA, Gilbert DL.
Stability of amphotericin B cholesteryl sulfate complex after reconstitution and admixture.
Hosp Pharm 1998 ; 33: 1203-1207.
1982 Rivista Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2262 Rivista Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3578 Laboratorio Cisplatin - Summary of Product Characteristics
Accord Healthcare 2011
3644 Laboratorio Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010

  Mentions Légales